Health
UNILAG Researchers Collaboration With Global Consortium Unravels Novel Parkinson’s Genetics Risk Factor In Africans and African Admixed Populations
Photo : ▪︎Prof. Njideka Okubadejo, Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos.
Akoka, Lagos – Researchers from the University of Lagos are key collaborators in the Global Parkinson’s Genetics Program (GP2) that uncovered a genetic variant that increases the risk of Parkinson’s Disease (PD) in Africans and African admixed populations.
The research finding was the result of teamwork by an international team including the Nigeria Parkinson Disease Research (NPDR) network, the International Parkinson’s Disease Genomics Consortium (IPDGC)-Africa, University College London, the National Institutes of Health (NIH) in
the US, and 23andMe.
The study was funded by the Michael J Fix foundation for Parkinson’s research and GP2.
The NPDR network and UNILAG team are led by a Professor of Neurology in the Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Professor Njideka Okubadejo who acknowledges the crucial role that the supportive research environment at the
university and the commitment of the national and international partners played in the success of the team.
She said “This GBA1 result is a step toward that future, where the research field is
prioritizing, learning from, and treating all people with Parkinson’s disease.”
Other members of the UNILAG team collaborating with the Global consortium (GP2) include: Dr. Oluwadamilola ‘Lara’ Ojo (Associate Professor and Site Lead Investigator, Faculty of
Clinical Sciences (FCS);
Dr. Osigwe Agabi (FCS);
Prof. Francis Ojini (FCS)
and Dr. Ismail Ishola (Faculty of Basic Medical Sciences (FBMS).
Others are Dr. Francisca Nwaokorie (Associate Professor, FBMS); Mr. Roosevelt Anyanwu (Central Research Laboratory CMUL), and Dr. Arinola Sanyaolu (FBMS).
The variant on the GBA1 gene was identified by the GP2 researchers as part of efforts to galvanize international/collaborative research into the genetics of Parkinson’s Disease (PD) as well as revolutionize treatment for the African and African admixed population.
While more research is needed to define the exact mechanism of the new variant, initial findings also suggest that like prior mutations in GBA1, this variant results in lowered activity of the glucocerebrosidase (GCase) enzyme.
The Global Parkinson’s Genetics Program (GP2) is a resource programme of the Aligning Science Across Parkinson’s (ASAP) initiative, it is funded by the Sergey Brin Family Foundation and implemented by The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
The Aligning Science Across Parkinson’s (ASAP) launched GP2 in 2019 to follow up on previous funding efforts from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) with a view to expanding global genetics study in populations traditionally underrepresented in research.
Till date, the GP2 is partnering with over 140 cohorts from around the world, assembling,
generating and sharing data to uncover novel insights and similarities in Parkinson’s Disease (PD).
The Vice-Chancellor, University of Lagos, Professor Folasade Ogunsola, on behalf of the University Senate, Management, Staff and Students, congratulates the UNILAG team on the GP2 project for their impact in the latest discovery.
Professor Ogunsola says the UNILAG team’s input and impact on the GP2 further accentuates the university’s fast migration into a Future-Ready institution with imprints in various fields including
Science.
Health
Pharmacists body urges FG to establish presidential committee for sector
The association noted that local drug production currently accounts for just over 38 percent of national demand, far below the 70 percent target set in the National Drug Policy 2021.
The Association of Community Pharmacists of Nigeria (ACPN) urges the Federal Government to establish a presidential committee dedicated to the pharmaceutical sector, implementing the National Drug Distribution Guidelines, and strengthening existing laws against fake drugs.
ACPN made the call while reacting to the government’s recent ban on imported drugs, describing the move as a strategic step toward strengthening local pharmaceutical manufacturing and conserving foreign exchange.
In a statement jointly signed by its National Chairman, Ambrose Ezeh and National Secretary, Omokhafe Ashore, the association said the updated prohibition schedule covering drugs under HS Codes 3003.10.00.00 through 3004.90.00 signals renewed commitment to protecting domestic industry players.
The ACPN specifically highlighted the ban on the importation of commonly used medicines such as paracetamol tablets and syrups, metronidazole, clotrimazole, chloroquine, multivitamins, aspirin and folic acid, as well as topical preparations like penicillin and gentamycin ointments.
It described the development as a “step in the right direction” that would boost investor confidence in Nigeria’s pharmaceutical sector.
The association noted that local drug production currently accounts for just over 38 percent of national demand, far below the 70 percent target set in the National Drug Policy 2021.
It attributed this gap partly to continued dependence on imports, especially from China and India, which it said accounts for about 65 per cent of drug supply in the country.
It also urged reforms in pharmaceutical education and training to expand the pool of skilled professionals across industry, clinical, hospital and community practice.
Health
2026 World Malaria Day: WHO lists 5 steps to eliminate malaria by 2030
World Malaria Day 2026 is observed on April 25th under the theme “Driven to End Malaria: Now We Can. Now We Must”
The World Health Organization (WHO) has listed five priority steps that could be taken by malaria-endemic countries especially in Africa to achieve the 2030 global target of eliminating malaria.
WHO emphasises the need for global malaria eradication marking the 2026 World Malaria Day with the theme: “Driven to End Malaria: Now We Can. Now We Must”
World Malaria Day 2026 is observed on April 25th under the theme “Driven to End Malaria: Now We Can. Now We Must”.
It highlights the potential to eliminate malaria in our lifetime, supported by new vaccines and next-generation nets, while urging immediate, accelerated action to address rising threats.
First, WHO said that countries must lead the malaria response with strong national ownership. It noted that when governments prioritize malaria as a dividend of national development and mobilize domestic resources, they lay the foundation for sustainable impact.
Second, it suggested a strategic intelligence action. It noted that robust surveillance systems, improved use of evidence and data analytics allow countries to anticipate threats, deploy interventions more effectively and ensure that resources are used where they can achieve the greatest impact.
Third, it highlighted that innovation must be accelerated and scaled equitably.
WHO said the introduction of malaria vaccines, new vector control tools, and improved treatment strategies represents a major step forward.
At the same time, strengthening Africa’s research capacity and regional manufacturing can help ensure that innovation benefits those who need it most.
Fourth, it insisted that Primary Health Care (PHC) centres must remain at the center of the malaria response. And that people-centered health services delivered through strong community platforms enable early diagnosis, timely treatment and sustained prevention.
And fifth, WHO noted that ending malaria requires a whole-of-society effort. Environmental, social and economic factors shape malaria transmission.
Health
Cross River identifies 10 more persons with COVID symptoms
The epidemiologist reminded members of the public that COVID-19, which broke out six years ago, had not been totally eliminated.
The Cross River State government that contact tracing carried out by health officials have dentified and isolated 10 persons who interacted with the Chinese national who reimported COVID-19 into Nigeria.
The State’s Epidemiologist, Dr Inyang Ekpenyong, said that her team visited the Chinese national’s work place in Akamkpa Local Government Area of the state.
“They were identified during contact tracing carried out by health officials. We’ve restricted their movements to their homes, so that they do not spread the symptoms to other persons, she said.”
The epidemiologist reminded members of the public that COVID-19, which broke out six years ago, had not been totally eliminated.
She cautioned people to habitually sanitise their hands, use nose masks, and adhere to other prescriptions by experts.
-
News3 days agoEdun, Dangiwa quit Tinubu’s cabinet * Oyedele becomes Finance Minister
-
News2 days agoLASG Fixes Last Saturdays Monthly Environmental Sanitation 6:30 am – 8:30 am
-
Health3 days agoCross River reports case of COVID-19
-
News2 days agoJUST IN: Alleged Coup Plotters Set for Arraignment at Noon Wednesday
-
Politics2 days agoPolice Disrupt BAT/OGD Rally in Ogun
-
News3 days agoArise News anchor Somtochukwu Maduagwu: Witness Discloses How Police Rounded Up Assailants
-
News2 days agoKano: Gov Yusuf Nominates Murtala Garo as Deputy Governor
-
Crime2 days agoAngwa-Rukuba killings: Plateau Government Files Charges Against Five Suspects Arrested By DSS
